Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neuroethics|October 17, 2022
Opportunity Cost or Opportunity Lost: An Empirical Assessment of Ethical Concerns and Attitudes of EEG Neurofeedback UsersLouiza Kalokairinou, Rebekah Choi, Ashwini Nagappan, et al.
Journal of Cognitive Enhancement : Towards the Integration of Theory and Practice|June 24, 2021
Neuroenhancement for sale: assessing the website claims of neurofeedback providers in the United StatesAnna Wexler, Ashwini Nagappan, Deena Kopyto, et al.
BMC Pregnancy and Childbirth|June 16, 2022
Pregnant at the start of the pandemic: a content analysis of COVID-19-related posts on online pregnancy discussion boardsRebekah Choi, Ashwini Nagappan, Deena Kopyto, et al.
Journal of the American Dental Association (1939)|July 29, 2020
Direct-to-consumer orthodontics: surveying the user experienceAnna Wexler, Ashwini Nagappan, Andrew Beswerchij, et al.
Biosocieties|June 26, 2023
Navigating biosafety concerns within COVID-19 do-it-yourself (DIY) science: an ethnographic and interview studyAnna Wexler, Rebekah Choi, Alex Pearlman, et al.
BMJ Open|March 29, 2024
Qualitative study of perceptions of factors contributing to success or failure among participants in a US weight loss trial of financial incentives and environmental change strategiesKaren Glanz, Collin Kather, Annie Chung, et al.
Plos One|April 15, 2020
Pregnancy and health in the age of the Internet: A content analysis of online "birth club" forumsAnna Wexler, Anahita Davoudi, Davy Weissenbacher, et al.
Contemporary Clinical Trials|November 21, 2018
The Healthy Weigh study of lottery-based incentives and environmental strategies for weight loss: Design and baseline characteristicsKaren Glanz, Pamela A Shaw, Karen Hoffer, et al.
JAMA Network Open|September 7, 2021
Effect of Financial Incentives and Environmental Strategies on Weight Loss in the Healthy Weigh Study: A Randomized Clinical TrialKaren Glanz, Pamela A Shaw, Pui L Kwong, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2009
Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)Daqing Sun, Zhulun Wang, Mario Cardozo, et al.
Pageof 2